日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Scalable TCR synthesis and screening enable antigen reactivity mapping in vitiligo.

可扩展的 TCR 合成和筛选能够绘制白癜风中的抗原反应图谱。

Gaglione Stephanie A, Mukkamala Rachit S, Krishna Chirag, Smith Blake E, Wadsworth Marc H 2nd, Jelinsky Scott A, Perez Caleb R, Schmidt-Hong Laura, Katz Erica L, Gellatly Kyle J, Ali Lestat R, Shen Jiao, Holec Patrick V, Zhao Qingyang Henry, Chan Amanda O, Xu Ellen J K, Kravarik Kellie M, Guzova Julia A, Dobson Connor S, Singh Harshabad, Garber Manuel, Dougan Michael, Dougan Stephanie K, Harris John E, Winkler Aaron, Birnbaum Michael E

Integrated inference of cancer gene expression from cell-free plasma chromatin.

从无细胞血浆染色质中综合推断癌症基因表达。

Gulati Gunsagar S, Vasseur Damien, Nawfal Rashad, Sotudian Shahabeddin, Semaan Karl, Eid Marc, Seo Ji-Heui, Phillips Noa, Canniff John J, Savignano Hunter, Chhetri Surya B, Jin Zhenjie, Ou Yukun, Bani Mohamed-Amine, Mary Lee Gwo-Shu, Trowbridge Rachel, Epstein Ilana B, Rickards Gabriella, Cordeiro Paulo Roberto Da Silva, Zhang Ze, Chehade Razane El Hajj, James Brady, Massard Christophe, Italiano Antoine, Hollebecque Antoine, Soria Jean-Charles, André Fabrice, Badoual Cécile, Bellmunt Joaquim, Singh Harshabad, Aguirre Andrew J, Wolpin Brian M, Choueiri Toni K, Baca Sylvan C, Freedman Matthew L

Crypt density and recruited enhancers underlie intestinal tumour initiation.

隐窝密度和募集的增强子是肠道肿瘤发生的基础

Gaynor Liam, Singh Harshabad, Tie Guodong, Badarinath Krithika, Madha Shariq, Mancini Andrew, Bhattacharya Swarnabh, Hoshino Mikio, de Sauvage Frederic J, Murata Kazutaka, Jadhav Unmesh, Shivdasani Ramesh A

A Phase 2 Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2

一项针对携带 ATM、BRCA1、BRCA2、PALB2 和 CHEK2 致病性变异的晚期胰腺癌患者的 Niraparib II 期试验

Huffman, Brandon M; Diossy, Miklos; Yurgelun, Matthew B; Horick, Nora; Li, Yvonne Y; Crowdis, Jett; Nguyen, Huy; Parmar, Kalindi; Kochupurakkal, Bose S; Vonk, Leonard; Lam, Helen; Ramsey, Kaitlyn; Andrews, Elizabeth; Loeb, Sarah C; Culnane, Leigh; Biller, Leah H; Bullock, Andrea J; Enzinger, Andrea; Giannakis, Marios; Jackson, Nadine A; Ng, Kimmie; Nowak, Jonathan A; Patel, Anuj K; Perez, Kimberly J; Rattani, Ahmed; Rubinson, Douglas A; Schlechter, Benjamin L; Singh, Harshabad; Cai, Mingyang; Raghavan, Srivatsan; Clark, Jefferey W; Peters, Mary Linton; Weipert, Caroline M; Wolpin, Brian M; D'Andrea, Alan D; Shapiro, Geoffrey I; Aguirre, Andrew J; Szallasi, Zoltan; Cleary, James M

Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma.

胰腺腺癌中 KRAS 密码子 12 特定变异的独特分子和临床特征

Ardalan Bach, Ciner Aaron, Baca Yasmine, Hinton Andrew, Darabi Sourat, Kasi Anup, Lou Emil, Azqueta Jose Ignacio, Xiu Joanne, Datta Jashodeep, Shields Anthony F, Aguirre Andrew, Singh Harshabad, Shroff Rachna T, Pishvaian Michael J, Goel Sanjay

Integrative genomic identification of therapeutic targets for pancreatic cancer

整合基因组学方法鉴定胰腺癌治疗靶点

Guo, Jimmy A; Gong, Dennis; Evans, Kyle; Takahashi, Kazuki; Jambhale, Ananya D; Shiau, Carina; Yu, Patrick; Wang, Steven; Wu, Wenbo W; Chugh, Seema; Kapner, Kevin S; Dilly, Julien; Zhao, Daniel; Chen, Peter; Smith, Eric L; Mancias, Joseph D; Vazquez, Francisca; Singh, Harshabad; Hwang, William L; Aguirre, Andrew J

Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma

CAPOX BETR 的临床结果和 ctDNA 相关性:一项卡培他滨、奥沙利铂、贝伐珠单抗、曲妥珠单抗治疗既往未接受治疗的晚期 HER2+ 胃食管腺癌的 II 期试验

Singh, Harshabad; Lowder, Kristen E; Kapner, Kevin; Kelly, Ronan J; Zheng, Hui; McCleary, Nadine Jackson; Abrams, Thomas A; Chan, Jennifer A; Regan, Eileen M; Klempner, Samuel J; Hannigan, Alison M; Remland, Joshua; Brais, Lauren K; Andrews, Elizabeth; Yurgelun, Matthew; Cleary, James M; Rubinson, Douglas A; Ritterhouse, Lauren L; Maron, Garrett; Aguirre, Andrew J; Meyerhardt, Jeffrey A; Gardecki, Emma; Lennerz, Jochen K; Wolpin, Brian M; Enzinger, Peter C

Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders

帕博利珠单抗治疗晚期肛门鳞状细胞癌疗效的生物标志物:一项 II 期临床试验和长期缓解者队列研究的分析

Huffman, Brandon M; Singh, Harshabad; Ali, Lestat R; Horick, Nora; Wang, S Jennifer; Hoffman, Megan T; Metayer, Katherine A; Murray, Shayla; Bird, Alexandra; Abrams, Thomas A; Biller, Leah H; Chan, Jennifer A; Meyerhardt, Jeffrey A; McCleary, Nadine J; Goessling, Wolfram; Patel, Anuj K; Wisch, Jeffrey S; Yurgelun, Matthew B; Mouw, Kent; Reardon, Brendan; Van Allen, Eliezer M; Zerillo, Jessica A; Clark, Jeffrey W; Parikh, Aparna; Mayer, Robert J; Schlechter, Benjamin; Ng, Kimmie; Kumar, Sunil; Del Vecchio Fitz, Catherine; Kuperwasser, Charlotte; Hanna, Glenn J; Coveler, Andrew L; Rubinson, Douglas A; Welsh, Emma L; Pfaff, Kathleen; Rodig, Scott; Dougan, Stephanie K; Cleary, James M

Clinical and Genomic Features of Classical and Basal Transcriptional Subtypes in Pancreatic Cancer

胰腺癌经典型和基底型转录亚型的临床和基因组特征

Singh, Harshabad; Xiu, Joanne; Kapner, Kevin S; Yuan, Chen; Narayan, Raja R; Oberley, Matthew; Farrell, Alex; Surana, Rishi; Huffman, Brandon M; Perez, Kimberly; Cleary, James M; Jordan, Alexander C; Dias Costa, Andressa; Williams, Hannah L; Raghavan, Srivatsan; Weinberg, Benjamin; Pishvaian, Michael J; Shroff, Rachna T; Goel, Sanjay; Dougan, Stephanie K; Nowak, Jonathan A; Spetzler, David; Sledge, George; Wolpin, Brian M; Aguirre, Andrew J

RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

RAS/RAF 计算和 ERBB2 拷贝数调节结直肠癌中 HER2 异质性和对 HER2 靶向治疗的响应性

Harshabad Singh, Pranshu Sahgal, Kevin Kapner, Steven M Corsello, Hersh Gupta, Rahul Gujrathi, Yvonne Y Li, Andrew D Cherniack, Raquelle El Alam, Joseph Kerfoot, Elizabeth Andrews, Annette Lee, Chetan Nambiar, Alison M Hannigan, Joshua Remland, Lauren Brais, Meghan E Leahy, Douglas A Rubinson, Benja